Rani-Logo.jpg
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
June 24, 2024 07:00 ET | Rani Therapeutics, LLC
~ New RT-114 obesity program combines ProGen’s FC Fusion protein conjugated GLP-1/GLP-2 dual agonist, PG-102, with the RaniPill® capsule designed to provide a differentiated oral delivery mechanism...
High Use of Ozempic and Other Diabetes Drugs for Weight Loss Driving Down Clothing Sizes In New York City, According to New Study
June 17, 2024 07:00 ET | Impact Analytics
Impact Analytics announced that size small has become the most popular size for women on Manhattan’s Upper East Side.
Noom Executives
Noom Announces Strategic Expansion of Executive Team with Key Leadership Appointments
June 13, 2024 12:14 ET | Noom Inc
Noom, the leading digital healthcare company, announces the appointment of three distinguished executives to its leadership team.
July 30, 2021 - ROSEN LOGO.jpg
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
May 27, 2024 10:31 ET | The Rosen Law Firm PA
NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and...
ResMed logo-fullcolor.jpg
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
May 23, 2024 09:05 ET | ResMed Inc.
New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
202306_Press Release-Amplify.png
Amplify ETFs Launches The Amplify Weight Loss Drug & Treatment ETF (THNR)
May 21, 2024 07:00 ET | Amplify ETFs
Amplify ETFs announces the launch of the Amplify Weight Loss Drug & Treatment ETF (NYSE: THNR).
July 30, 2021 - ROSEN LOGO.jpg
ALT INVESTOR NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
May 09, 2024 14:52 ET | The Rosen Law Firm PA
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of...
Noom FitOn
Noom Adds Muscle Defense™ to Its GLP-1 Companion Program to Help Prevent Muscle-Mass Loss While Taking GLP-1s
May 09, 2024 08:04 ET | Noom Inc
Noom launches Noom Move, an on-demand fitness offering, including Muscle Defense™, a curated movement program for those taking GLP-1 medications.
Beauty Right Introduces "Dietary Nutritional Supplement" with GLP-1 Active Peptide Capsules
Beauty Right Introduces "Dietary Nutritional Supplement" with GLP-1 Active Peptide Capsules
April 22, 2024 08:00 ET | Beauty Right
New York, April 22, 2024 (GLOBE NEWSWIRE) -- Beauty Right, a brand specializing in dietary supplements, introduces GLP-1 Active Peptide Capsules, a nutritional supplement designed to help people...
Costco unveils new weight loss service with healthcare partner Sesame
Wholesale Weight Loss: Sesame Unveils Specialized Care for Weight Loss with Pricing Exclusively for Costco Members
April 02, 2024 10:59 ET | Sesame
NEW YORK CITY, April 02, 2024 (GLOBE NEWSWIRE) -- Sesame, the company building a radically new healthcare system for uninsured Americans and those with high-deductible plans,  today unveiled an...